Direct-to-consumer genetic-testing companies were in the hot seat this week, with scrutiny from both the FDA and Congress. Fodder for some of the discussion was a new GAO report that focused on the scientific accuracy and marketing efforts of tests by companies including 23andMe, Pathway Genomics, deCODE genetics and Navigenics. You can read about the GAO report in this story from today’s WSJ. And here’s the GAO report itself. But for some Friday fun, listen to or read the transcripts of undercover calls to unnamed genetic-testing companies made by GAO investigators. (Undercover contact was made with 15 companies, including the four listed above.) |
No comments:
Post a Comment